Why the study?
Despite the major role of myocardial fibrosis in cardiac dysfunction and heart failure, limited clinical interventions effectively target the cardiac fibroblast and fibrotic tissue deposition.
Design
Review
Loading...
Epigenetic targets remain experimental for cardiac fibrosis; leaves open validation in prospective trials before any clinical consideration.
Key points are not available for this paper at this time.
A 2022 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: